Rank,NCT Number,Title,Conditions,Interventions,Title_condition_intervention,Types
1,NCT03442010,Adverse Drug Events at Emergency Department,Adverse Drug Event,Other Detection of adverse drug events,Adverse Drug Events at Emergency Department Adverse Drug Event Other Detection of adverse drug events,Drugs
1,NCT03158831,Drug Challenges Without Prior Skin Testing,Drug Hypersensitivity Penicillin Allergy Antibiotic Allergy,Drug Placebo-Controlled Graded Drug Challenge,Drug Challenges Without Prior Skin Testing Drug Hypersensitivity Penicillin Allergy Antibiotic Allergy Drug Placebo Controlled Graded Drug Challenge,Drugs
1,NCT03476733,Incidence and Risk Factor of Drug Related Problem Detected in Inpatient,Drug Related Problem,Other Detection of drug related problem in inpatient,Incidence and Risk Factor of Drug Related Problem Detected in Inpatient Drug Related Problem Other Detection of drug related problem in inpatient,Drugs
1,NCT02838212,Adverse Drug Reactions With Fatal Outcome,Adverse Drug Reaction,Drug adverse drug reaction,Adverse Drug Reactions With Fatal Outcome Adverse Drug Reaction Drug adverse drug reaction,Drugs
1,NCT02839551,Optimal Doses for Drug Provocation Tests to Beta-lactams,Drug Hypersensitivity,Procedure simplified drug provocation test,Optimal Doses for Drug Provocation Tests to Beta lactams Drug Hypersensitivity Procedure simplified drug provocation test,Drugs
1,NCT03899922,Monitoring Drug-induced Uveitis,Uveitis Uveitis Drug-Induced Eye Diseases Uvea--Diseases,Drug Drugs inducing uveitis,Monitoring Drug induced Uveitis Uveitis Uveitis Drug Induced Eye Diseases Uvea Diseases Drug Drugs inducing uveitis,Drugs
1,NCT03804905,STUDIIO-Diabetes Pilot STUdy of Drug Insurance to Improve Outcomes of Diabetes,Type 2 Diabetes Mellitus Medication Adherence Medication Compliance Medication Nonadherence,Other Drug cards,STUDIIO Diabetes Pilot STUdy of Drug Insurance to Improve Outcomes of Diabetes Type 2 Diabetes Mellitus Medication Adherence Medication Compliance Medication Nonadherence Other Drug cards,Drugs
1,NCT01239121,Regional Data Exchange to Improve Medication Safety,Drug Toxicity,Other HIE-Enhanced Medication Reconciliation Other Optimal Medication Reconciliation without HIE,Regional Data Exchange to Improve Medication Safety Drug Toxicity Other HIE Enhanced Medication Reconciliation Other Optimal Medication Reconciliation without HIE,Drugs
1,NCT03316014,Adverse Drug Reactions in Pediatrics Experience of a Regional Pharmacovigilance Center,Child With Adverse Drug Reactions,Other Adverse drug reaction,Adverse Drug Reactions in Pediatrics Experience of a Regional Pharmacovigilance Center Child With Adverse Drug Reactions Other Adverse drug reaction,Drugs
1,NCT01531088,Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes,Adverse Drug Events,Behavioral Active medication monitoring,Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes Adverse Drug Events Behavioral Active medication monitoring,Drugs
1,NCT03947034,Monitoring the Hyperammonaemia TOXicity of Drugs (AmmoTOX),Hyperammonemia Metabolic Disease Adverse Drug Event Drug Toxicity,Drug Drugs inducing hyperammonemia,Monitoring the Hyperammonaemia TOXicity of Drugs (AmmoTOX) Hyperammonemia Metabolic Disease Adverse Drug Event Drug Toxicity Drug Drugs inducing hyperammonemia,Drugs
1,NCT04252326,The Knowledge Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children,Adverse Drug Reactions,Other Survey,The Knowledge Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children Adverse Drug Reactions Other Survey,Drugs
1,NCT02888834,Serious Adverse Drug Reaction and Their Preventability,Adverse Drug Reaction,Other Adverse drug reaction,Serious Adverse Drug Reaction and Their Preventability Adverse Drug Reaction Other Adverse drug reaction,Drugs
1,NCT02805270,Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization,Adverse Drug Events,Other medication reconciliation intervention,Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization Adverse Drug Events Other medication reconciliation intervention,Drugs
1,NCT01683227,Screening Brief Intervention and Referral to Treatment for Drug Use,Drug Abuse,Behavioral Screening/motivational drug intervention Behavioral Motivational placebo intervention,Screening Brief Intervention and Referral to Treatment for Drug Use Drug Abuse Behavioral Screening motivational drug intervention Behavioral Motivational placebo intervention,Drugs
1,NCT03630692,Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs,Metastatic Renal Cancer Stage III Renal Cell Cancer,Drug observance of oral drug treatment,Safety and Compliance of Renal Cancer Patients Treated by Non IV Drugs Metastatic Renal Cancer Stage III Renal Cell Cancer Drug observance of oral drug treatment,Drugs
1,NCT03994302,Monitoring the Antiphospholipid Syndrome TOXicity of Drugs (APSTOX),Antiphospholipid Syndrome Immune Disease Adverse Drug Event Drug Toxicity,Drug Drug inducing antiphospholipid syndrome,Monitoring the Antiphospholipid Syndrome TOXicity of Drugs (APSTOX) Antiphospholipid Syndrome Immune Disease Adverse Drug Event Drug Toxicity Drug Drug inducing antiphospholipid syndrome,Drugs
1,NCT03176342,Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs),Drug Reaction,Other patch test,Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs) Drug Reaction Other patch test,Drugs
1,NCT01467050,Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients,Adverse Drug Reaction,Other Application of STOPP/START criteria Other Normal pharmaceutical care,Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients Adverse Drug Reaction Other Application of STOPP START criteria Other Normal pharmaceutical care,Drugs
1,NCT01364324,Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients,Tuberculosis Tuberculosis Pulmonary Early Gastric Cancer,Drug standard first line anti-TB drugs,Pharmacokinetics of Anti tuberculosis Drugs in Gastrectomized Patients Tuberculosis Tuberculosis Pulmonary Early Gastric Cancer Drug standard first line anti TB drugs,Drugs
1,NCT03352206,Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis,Lymphatic Filariases,Drug 2 drug dose - DA Drug 3 drug dose - IDA,Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis Lymphatic Filariases Drug 2 drug dose  DA Drug 3 drug dose  IDA,Drugs
1,NCT03855982,Monitoring Drug-induced Myocarditis (CardiTOX),Myocarditis Myocardial Failure Myocardial Dysfunction,Drug Drug inducing myocarditis,Monitoring Drug induced Myocarditis (CardiTOX) Myocarditis Myocardial Failure Myocardial Dysfunction Drug Drug inducing myocarditis,Drugs
1,NCT01179867,Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge,Medication Reconciliation Adverse Drug Events,Other Electronic Medication Reconciliation,Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge Medication Reconciliation Adverse Drug Events Other Electronic Medication Reconciliation,Drugs
1,NCT03165175,Mobile Application for Prescription Drug-Abuse Education (MAPDE),Prescription Drug Abuse (Not Dependent),Behavioral prescription drug-abuse education smartphone application,Mobile Application for Prescription Drug Abuse Education (MAPDE) Prescription Drug Abuse (Not Dependent) Behavioral prescription drug abuse education smartphone application,Drugs
1,NCT03829995,Effect of Pharmacist Provided Drug Information Services After Hospital Discharge,Drug Counseling,Other Drug counseling,Effect of Pharmacist Provided Drug Information Services After Hospital Discharge Drug Counseling Other Drug counseling,Drugs
1,NCT02899936,Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis,Lymphatic Filariasis,Drug 3 drug dose - IDA Drug 2 drug dose - DA,Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis Lymphatic Filariasis Drug 3 drug dose  IDA Drug 2 drug dose  DA,Drugs
1,NCT03607097,Integral Management of Healthcare Problems Related With Drugs in Polimedicated Patients Medication Code,Drug Related Problems Pharmaceutical Care,Procedure Secondary prevention program for drug related problems,Integral Management of Healthcare Problems Related With Drugs in Polimedicated Patients Medication Code Drug Related Problems Pharmaceutical Care Procedure Secondary prevention program for drug related problems,Drugs
1,NCT01189305,Behavioral Couples Therapy for Female Drug-Abusing Patients,Drug Abuse,Behavioral Behavioral Couples Therapy Behavioral Individual Drug Counseling,Behavioral Couples Therapy for Female Drug Abusing Patients Drug Abuse Behavioral Behavioral Couples Therapy Behavioral Individual Drug Counseling,Drugs
1,NCT02026453,Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy,Adverse Drug Events,Other Pharmacist obtains admission medication history Other Pharmacy technician obtains admission medication history,Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy Adverse Drug Events Other Pharmacist obtains admission medication history Other Pharmacy technician obtains admission medication history,Drugs
1,NCT01942876,Preventing Drug Use in Low Income Clinic Populations,Drug Use Harmful Use,Behavioral Quit Using Drugs Intervention Trial Behavioral Health behavior maintenance,Preventing Drug Use in Low Income Clinic Populations Drug Use Harmful Use Behavioral Quit Using Drugs Intervention Trial Behavioral Health behavior maintenance,Drugs
1,NCT03482817,Drug Cocktail Interaction Study of St. John's Wort Dry Extract Ze 117,Drug Interaction Study,Drug Ze 117 Drug Probe drug cocktail,Drug Cocktail Interaction Study of St. John's Wort Dry Extract Ze 117 Drug Interaction Study Drug Ze 117 Drug Probe drug cocktail,Drugs
1,NCT03335137,Determining Drug Levels of Beta-lactam Antibiotics in Severe Burned Patients,Antibiotics Severe Burn Intensive Care,Diagnostic Test Drug Level Monitoring,Determining Drug Levels of Beta lactam Antibiotics in Severe Burned Patients Antibiotics Severe Burn Intensive Care Diagnostic Test Drug Level Monitoring,Drugs
1,NCT01337063,Multi-Center Medication Reconciliation Quality Improvement Study,Adverse Drug Events Medication Administered in Error,Other Mentored medication reconciliation quality improvement,Multi Center Medication Reconciliation Quality Improvement Study Adverse Drug Events Medication Administered in Error Other Mentored medication reconciliation quality improvement,Drugs
1,NCT03828942,Monitoring the HeMAtological TOXicity of Drugs (HeMATOX),Hematological Abnormality Hematotoxicity,Drug drug inducing hematological toxicity,Monitoring the HeMAtological TOXicity of Drugs (HeMATOX) Hematological Abnormality Hematotoxicity Drug drug inducing hematological toxicity,Drugs
1,NCT03833297,Monitoring the HePAtological TOXicity of Drugs (HePATOX),Liver Diseases Liver Dysfunction Liver Failure Hepatotoxicity,Drug Drugs inducing hepatological toxicity,Monitoring the HePAtological TOXicity of Drugs (HePATOX) Liver Diseases Liver Dysfunction Liver Failure Hepatotoxicity Drug Drugs inducing hepatological toxicity,Drugs
1,NCT03183076,Efficacy Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy,Epilepsy Drug Resistant,Other modified adkins diet Drug Pharmacotherapy without diet,Efficacy Tolerability and Adherence of the Modified Atkins Diet on Drug resistant Epilepsy Epilepsy Drug Resistant Other modified adkins diet Drug Pharmacotherapy without diet,Drugs
1,NCT03515772,Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients,HIV Infections Drug Interactions Cardiovascular Diseases,Drug Co-administration of darunavir with a cardiovascular drug,Drug drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients HIV Infections Drug Interactions Cardiovascular Diseases Drug Co administration of darunavir with a cardiovascular drug,Drugs
1,NCT04124055,Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania,MDR-TB,Diagnostic Test Therapeutic drug monitoring (TDM),Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR TB in Tanzania MDR TB Diagnostic Test Therapeutic drug monitoring (TDM),Drugs
1,NCT01602744,The Use of STOPP/START Criteria for Medication Intervention Among Elderly Population Living in a Geriatric Hospital,Adverse Drug Effects,Other STOPP/START screening tools for medication intervention,The Use of STOPP START Criteria for Medication Intervention Among Elderly Population Living in a Geriatric Hospital Adverse Drug Effects Other STOPP START screening tools for medication intervention,Drugs
1,NCT03830671,The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB,Multi-drug Resistant Tuberculosis,Drug 18-month regimen containing 6 anti-TB drugs,The Effect of 18 month Regimen Containing 6 Anti tuberculosis Drugs for Patients With MDR TB Multi drug Resistant Tuberculosis Drug 18 month regimen containing 6 anti TB drugs,Drugs
1,NCT02413957,Medication Reconciliation in Comparison to an Extensive Medication Safety Check,Elderly Adverse Drug Event,Other Medication Reconciliation Other Pharmaceutical Care,Medication Reconciliation in Comparison to an Extensive Medication Safety Check Elderly Adverse Drug Event Other Medication Reconciliation Other Pharmaceutical Care,Drugs
1,NCT01814280,Reducing Medication Errors on Basis of an Individual Risk Assessment,Drug Safety,Other Medication review,Reducing Medication Errors on Basis of an Individual Risk Assessment Drug Safety Other Medication review,Drugs
1,NCT02869724,Divided Drug Delivery,Hospitalized for Voluntary Drug Intoxication,Other Weekly divided delivery Other Monthly divided delivery,Divided Drug Delivery Hospitalized for Voluntary Drug Intoxication Other Weekly divided delivery Other Monthly divided delivery,Drugs
1,NCT02222389,Contingency Management for the Treatment of Co-Occurring Alcohol and Drug Misuse,Co-Occurring Alcohol and Drug Misuse,Behavioral CM for Alcohol Behavioral CM for drugs Behavioral CM for both substances Behavioral Non-Contingent group,Contingency Management for the Treatment of Co Occurring Alcohol and Drug Misuse Co Occurring Alcohol and Drug Misuse Behavioral CM for Alcohol Behavioral CM for drugs Behavioral CM for both substances Behavioral Non Contingent group,Drugs
1,NCT03373825,Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs,Accidental Overdose of Opiate,Behavioral Take home rapid drug test,Rapid Self Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs Accidental Overdose of Opiate Behavioral Take home rapid drug test,Drugs
1,NCT02632955,Drug Eluting Balloon for Early Fistula Failure Trial,Stenosis of Arteriovenous Dialysis Fistula,Drug Drug Eluting Balloon Procedure Regular angioplasty,Drug Eluting Balloon for Early Fistula Failure Trial Stenosis of Arteriovenous Dialysis Fistula Drug Drug Eluting Balloon Procedure Regular angioplasty,Drugs
1,NCT02906657,Medication Reconciliation Using Electronic Pharmaceutical Record A Multicenter Study in the Hospitalized Elderly,Adverse Drug Event,Other Medication reconciliation,Medication Reconciliation Using Electronic Pharmaceutical Record A Multicenter Study in the Hospitalized Elderly Adverse Drug Event Other Medication reconciliation,Drugs
1,NCT03272607,Reducing Post-discharge Adverse Drug Events Amongst the Elderly a Multi-centre Electronic Deprescribing Intervention,Adverse Drug Event,Other Deprescribing opportunities,Reducing Post discharge Adverse Drug Events Amongst the Elderly a Multi centre Electronic Deprescribing Intervention Adverse Drug Event Other Deprescribing opportunities,Drugs
1,NCT01942811,BiNational Quit Using Drugs Intervention Trial,Drug Use Harmful Use,Behavioral Quit Using Drugs Intervention Trial,BiNational Quit Using Drugs Intervention Trial Drug Use Harmful Use Behavioral Quit Using Drugs Intervention Trial,Drugs
1,NCT02330250,Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment,Systemic Lupus Erythematosus Medication Adherence,Other Pharmaceutical Care Other Control,Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment Systemic Lupus Erythematosus Medication Adherence Other Pharmaceutical Care Other Control,Drugs
1,NCT04078620,Risk Factors for Potential Drug -Drug Interactions Study in Surgical Intensive Care Unit -Zagazig University Hospitals.,Drug Interaction,Diagnostic Test Survey for drug drug interactions on medscape and lexicomp applications,Risk Factors for Potential Drug Drug Interactions Study in Surgical Intensive Care Unit Zagazig University Hospitals. Drug Interaction Diagnostic Test Survey for drug drug interactions on medscape and lexicomp applications,Drugs
1,NCT01164137,Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care,Adverse Drug Events,Behavioral Medication Reconciliation,Eliminating Risk of Preventable Adverse Drug Events at the Hospital community Interface of Care Adverse Drug Events Behavioral Medication Reconciliation,Drugs
1,NCT03557021,Impact of HIV Drug Resistance Testing and Subsequent Change to an Individualized Therapy in Tanzania,HIV Drug Resistance,Diagnostic Test HIV Drug resistance testing,Impact of HIV Drug Resistance Testing and Subsequent Change to an Individualized Therapy in Tanzania HIV Drug Resistance Diagnostic Test HIV Drug resistance testing,Drugs
1,NCT02360371,Individual Differences in Drug Response,Individual Differences Pain Stress Impulsivity,Drug Within-subject assessment of double-blind study drug,Individual Differences in Drug Response Individual Differences Pain Stress Impulsivity Drug Within subject assessment of double blind study drug,Drugs
1,NCT03666520,Switching Medications From Intravenous to Oral,Physician's Role Administration Oral,Other Clinical Decision Support prompted to the clinician to convert drug.,Switching Medications From Intravenous to Oral Physician's Role Administration Oral Other Clinical Decision Support prompted to the clinician to convert drug.,Drugs
1,NCT01068847,Drug Discrimination in Methadone-Maintained Humans Study 3,Drug Dependence,Drug 2-4 of the drugs listed below,Drug Discrimination in Methadone Maintained Humans Study 3 Drug Dependence Drug 2 4 of the drugs listed below,Drugs
1,NCT01898052,The Efficacy of Periarticular Single Drug Compared With Multimodal Drug Injection in Controlling Pain After TKA,Postoperative Pain,Drug single anaesthetic drug Drug multimodal drug injection,The Efficacy of Periarticular Single Drug Compared With Multimodal Drug Injection in Controlling Pain After TKA Postoperative Pain Drug single anaesthetic drug Drug multimodal drug injection,Drugs
1,NCT04208789,Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis,MDR Tuberculosis Resistance to Tuberculostatic Drugs,Diagnostic Test Rapid Molecular Drug-Resistant Tuberculosis Test Other Artificial Intelligent Model Diagnostic Test Drug Susceptibility Test,Artificial Inteligent for Diagnosing Drug Resistant Tuberculosis MDR Tuberculosis Resistance to Tuberculostatic Drugs Diagnostic Test Rapid Molecular Drug Resistant Tuberculosis Test Other Artificial Intelligent Model Diagnostic Test Drug Susceptibility Test,Drugs
1,NCT03965286,Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital,Antiviral Drug,Drug DAAs,Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital Antiviral Drug Drug DAAs,Drugs
1,NCT03075501,Interactions Between Drug Effects and Environments,Substance-Related Disorders,Behavioral Paired Drug Stimulant or sedative Drug Placebo,Interactions Between Drug Effects and Environments Substance Related Disorders Behavioral Paired Drug Stimulant or sedative Drug Placebo,Drugs
1,NCT03652740,Effects of Commonly Used Medications on Mood and Choice,Healthy,Drug Effects of commonly used medications on mood and medication preference,Effects of Commonly Used Medications on Mood and Choice Healthy Drug Effects of commonly used medications on mood and medication preference,Drugs
1,NCT03181906,Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting,Medication Administered in Error Medication Adherence,Other Pre-Consultation Medication Reconciliation,Effectiveness of Pre Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting Medication Administered in Error Medication Adherence Other Pre Consultation Medication Reconciliation,Drugs
1,NCT02955875,Pharmaceutical Care Service in Diabetes,Diabetes Mellitus Type 2,Behavioral Pharmaceutical care,Pharmaceutical Care Service in Diabetes Diabetes Mellitus Type 2 Behavioral Pharmaceutical care,Drugs
1,NCT03451344,A Electronic System to Improve Recovery Outcomes in Patients With Drug Use Disorder,Drug Use Disorders Addiction Drug,Other Integrated rehabilitation group Other Community-based rehabilitation group,A Electronic System to Improve Recovery Outcomes in Patients With Drug Use Disorder Drug Use Disorders Addiction Drug Other Integrated rehabilitation group Other Community based rehabilitation group,Drugs
1,NCT03137641,Nurses Internal Contamination by Antineoplastic Drugs.,Antineoplastic Drugs Contamination Prevalence,Other Nurses urine samples,Nurses Internal Contamination by Antineoplastic Drugs. Antineoplastic Drugs Contamination Prevalence Other Nurses urine samples,Drugs
1,NCT01467128,Adverse Drug Event Prevention Using Structured Pharmacist Review,Adverse Drug Reactions,Other Structured expert pharmacist review Other No Intervention,Adverse Drug Event Prevention Using Structured Pharmacist Review Adverse Drug Reactions Other Structured expert pharmacist review Other No Intervention,Drugs
1,NCT03541421,Self-administration of Patients Own Drugs During Hospital Stay,Patient Involvement Medication Errors Self Administration Medication Adherence Patient Satisfaction Health Economics,Other Patient involvement in administration of drugs,Self administration of Patients Own Drugs During Hospital Stay Patient Involvement Medication Errors Self Administration Medication Adherence Patient Satisfaction Health Economics Other Patient involvement in administration of drugs,Drugs
1,NCT03736577,Psychotropic Drug Use in the Elderly Living in Nursing Homes and the Influence of a Structured Drug Review,Cognitive Symptom Depression Anxiety Neuropsychiatric Syndrome Quality of Life Activity of Daily Living Physical Health Drug Use,Other Drug reviews with NorGeP-NH,Psychotropic Drug Use in the Elderly Living in Nursing Homes and the Influence of a Structured Drug Review Cognitive Symptom Depression Anxiety Neuropsychiatric Syndrome Quality of Life Activity of Daily Living Physical Health Drug Use Other Drug reviews with NorGeP NH,Drugs
1,NCT03648411,Drug Resistance Among Asymptomatic Infection,Drug Resistant Malaria Asymptomatic Infections Migrant Workers,Genetic Drug resistance molecular markers,Drug Resistance Among Asymptomatic Infection Drug Resistant Malaria Asymptomatic Infections Migrant Workers Genetic Drug resistance molecular markers,Drugs
1,NCT02739282,Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs,Epilepsy,Other Systematic therapeutic drug monitoring,Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs Epilepsy Other Systematic therapeutic drug monitoring,Drugs
1,NCT00740675,Ambulatory Medication Reconciliation Following Hospital Discharge,Medication Administered in Error Adverse Drug Events,Other Outpatient Medication Reconciliation,Ambulatory Medication Reconciliation Following Hospital Discharge Medication Administered in Error Adverse Drug Events Other Outpatient Medication Reconciliation,Drugs
1,NCT02748148,Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice,Medication Therapy Management Pharmacogenomics,Other Medication therapy management,Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice Medication Therapy Management Pharmacogenomics Other Medication therapy management,Drugs
1,NCT01969305,Youth Drug Abuse Prevention in Kazakhstan,Drug Use,Behavioral Kazakhstani Family Together Behavioral Usual Care Alone,Youth Drug Abuse Prevention in Kazakhstan Drug Use Behavioral Kazakhstani Family Together Behavioral Usual Care Alone,Drugs
1,NCT03411122,A Study to Evaluate the Safety Tolerability Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy Volunteers,Drug-drug Interactions,Drug napabucasin Drug cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate,A Study to Evaluate the Safety Tolerability Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy Volunteers Drug drug Interactions Drug napabucasin Drug cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate,Drugs
1,NCT01845194,Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics,Drug Biotransformation Membrane Transport,Drug Codeine Drug Midazolam Drug Pravastatin Drug Torsemide Drug Talinolol Drug Caffeine Drug Metoprolol,Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics Drug Biotransformation Membrane Transport Drug Codeine Drug Midazolam Drug Pravastatin Drug Torsemide Drug Talinolol Drug Caffeine Drug Metoprolol,Drugs
1,NCT02375516,Preventing Drug Abuse Among Hispanic Adolescents,Drug Abuse,Behavioral Prevention Program,Preventing Drug Abuse Among Hispanic Adolescents Drug Abuse Behavioral Prevention Program,Drugs
1,NCT01584765,Rechallenge Potential Drug Induced Liver Injury (Kaiser),Drug-induced Liver Injury,Drug Prescription drugs with known hepatotoxicity,Rechallenge Potential Drug Induced Liver Injury (Kaiser) Drug induced Liver Injury Drug Prescription drugs with known hepatotoxicity,Drugs
1,NCT04166305,Drug Resistant Epilepsy Clinical and Genetic Study,Epilepsy Drug Resistant,Genetic Genetic study for SCN1A c.3184 A/G and CCL2-2518G>A polymorphism ,Drug Resistant Epilepsy Clinical and Genetic Study Epilepsy Drug Resistant Genetic Genetic study for SCN1A c.3184 A G and CCL2 2518G>A polymorphism ,Drugs
1,NCT03390465,Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects,Drug-Drug Interaction,Drug Fimasartan/Amlodipine combination drug Hydrochlorothiazide,Drug Interaction Study of Fimasartan Amlodipine Hydrochlorothiazide in Healthy Male Subjects Drug Drug Interaction Drug Fimasartan Amlodipine combination drug Hydrochlorothiazide,Drugs
1,NCT00198861,Neurobehavioral Model of HIV in Injection Drug Users,Drug Abuse HIV Infections,Other Injection and Non-Injection Drug Users,Neurobehavioral Model of HIV in Injection Drug Users Drug Abuse HIV Infections Other Injection and Non Injection Drug Users,Drugs
1,NCT01360463,Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta Indonesia,HIV Risk Behaviors Heroin Injection Retention in Methadone Treatment,Behavioral Behavioral Drug and Risk Counseling (BDRC) Behavioral methadone maintenance treatment,Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta Indonesia HIV Risk Behaviors Heroin Injection Retention in Methadone Treatment Behavioral Behavioral Drug and Risk Counseling (BDRC) Behavioral methadone maintenance treatment,Drugs
1,NCT03561298,A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects,Healthy Subjects,Drug BGB-3111 and Drug Cocktail,A Pharmacokinetic Study to Assess Drug drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects Healthy Subjects Drug BGB 3111 and Drug Cocktail,Drugs
1,NCT01406431,Pharmacokinetic Study of Livalo¶© Fixed Combination Drug in Healthy Subjects,Hyperlipidemia Hypertension,Drug Pitavastatin Valsartan Drug Livalo¶© fixed combination drug,Pharmacokinetic Study of Livalo¶© Fixed Combination Drug in Healthy Subjects Hyperlipidemia Hypertension Drug Pitavastatin Valsartan Drug Livalo¶© fixed combination drug,Drugs
1,NCT03706222,Drug-Drug Interactions of Grazoprevir/Elbasvir in Taiwan,Drug Interaction Potentiation,Drug elbasvir/grazoprevir,Drug Drug Interactions of Grazoprevir Elbasvir in Taiwan Drug Interaction Potentiation Drug elbasvir grazoprevir,Drugs
1,NCT01872819,Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay,Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Chronic Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts,Other antitumor drug screening assay Drug chemotherapy Biological biological therapy,Treatment for Relapsed Refractory AML Based on a High Throughput Drug Sensitivity Assay Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Chronic Myelomonocytic Leukemia Myelodysplastic Myeloproliferative Neoplasm Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Other antitumor drug screening assay Drug chemotherapy Biological biological therapy,Drugs
1,NCT02734966,Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury,Drug-Induced Liver Injury,Drug Magnesium Isoglycyrrhizinate Injection 100mg OD Drug Magnesium Isoglycyrrhizinate Injection 200mg OD Drug Tiopronin Injection,Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug induced Liver Injury Drug Induced Liver Injury Drug Magnesium Isoglycyrrhizinate Injection 100mg OD Drug Magnesium Isoglycyrrhizinate Injection 200mg OD Drug Tiopronin Injection,Drugs
1,NCT02771977,Drug-Targeted Alerts for Acute Kidney Injury,Acute Kidney Injury,Other Drug-specific alert,Drug Targeted Alerts for Acute Kidney Injury Acute Kidney Injury Other Drug specific alert,Drugs
1,NCT03156348,Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults,Drug-Related Side Effects and Adverse Reactions,Other Clinical Pharmacist Care,Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults Drug Related Side Effects and Adverse Reactions Other Clinical Pharmacist Care,Drugs
1,NCT01195051,Medication Reconciliation Technology to Improve Quality of Transitional Care,Medication Reconciliation,Other Electronic medication reconciliation,Medication Reconciliation Technology to Improve Quality of Transitional Care Medication Reconciliation Other Electronic medication reconciliation,Drugs
1,NCT03713983,Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder,Drug Use Disorders,Other Observational study,Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder Drug Use Disorders Other Observational study,Drugs
1,NCT02428660,Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM,Cytochrome P450 CYP2D6 Enzyme Deficiency Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant Cytochrome P450 CYP2C9 Enzyme Deficiency Cytochrome P450 CYP2C19 Enzyme Deficiency Drug Metabolism Poor CYP2D6-RELATED Drug Metabolism Poor CYP2C19-RELATED CYP2D6 Polymorphism,Genetic Pharmacogenetic testing Other Software-based drug & gene interaction risk analysis Other MTM,Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM Cytochrome P450 CYP2D6 Enzyme Deficiency Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant Cytochrome P450 CYP2C9 Enzyme Deficiency Cytochrome P450 CYP2C19 Enzyme Deficiency Drug Metabolism Poor CYP2D6 RELATED Drug Metabolism Poor CYP2C19 RELATED CYP2D6 Polymorphism Genetic Pharmacogenetic testing Other Software based drug & gene interaction risk analysis Other MTM,Drugs
1,NCT03671629,Pharmacist Intervention to Reduce Drug-related Readmissions Among the Elderly,Drug Use,Other Enhanced clinical pharmacist service,Pharmacist Intervention to Reduce Drug related Readmissions Among the Elderly Drug Use Other Enhanced clinical pharmacist service,Drugs
1,NCT04127305,Drug Monitoring in Critically Ill Patients During Extracorporeal Life Support,Drug Monitoring of Antiinfectives in Critically Ill Patients Receiving Extracorporeal Life Support,Other No Intervention,Drug Monitoring in Critically Ill Patients During Extracorporeal Life Support Drug Monitoring of Antiinfectives in Critically Ill Patients Receiving Extracorporeal Life Support Other No Intervention,Drugs
1,NCT03422484,SCORE of Medication Error in Internal Medecin Unit,Patient Hospitalized in Internal Medicine Unit,Other Detection and correction of medication error at hospital admission,SCORE of Medication Error in Internal Medecin Unit Patient Hospitalized in Internal Medicine Unit Other Detection and correction of medication error at hospital admission,Drugs
1,NCT02844712,Negative Predictive Value of Drug Provocation Tests to Beta-lactams,Drug Hypersensitivity,Other Evaluation of reexposure to a negatively tested betalactam,Negative Predictive Value of Drug Provocation Tests to Beta lactams Drug Hypersensitivity Other Evaluation of reexposure to a negatively tested betalactam,Drugs
1,NCT04130750,Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice,Breast Cancer Neoadjuvant Chemotherapy Drug Effect,Combination Product treatment of drug screening,Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice Breast Cancer Neoadjuvant Chemotherapy Drug Effect Combination Product treatment of drug screening,Drugs
1,NCT02457949,The Impact of Alternative Social Assistance Disbursement on Drug-related Harm,Drug Use,Other Non-synchronized social assistance receipt Other cheque divided into two equal disbursements,The Impact of Alternative Social Assistance Disbursement on Drug related Harm Drug Use Other Non synchronized social assistance receipt Other cheque divided into two equal disbursements,Drugs
2,NCT00809666,Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device,Hypertension Pregnancy Pre Eclampsia,Device Automated blood pressure recording device Omron HEM 705CP,Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device Hypertension Pregnancy Pre Eclampsia Device Automated blood pressure recording device Omron HEM 705CP,Devices
2,NCT02445313,Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device,Age-related Macular Degeneration (AMD),Device Nidek MP-3,Measuring Geographic Atrophy in AMD Patients Using the Nidek MP 3 Microperimetry Device Age related Macular Degeneration (AMD) Device Nidek MP 3,Devices
2,NCT02617472,Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI),Stress Urinary Incontinence Sexual Dysfunction,Device Pelvic floor exerciser,Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI) Stress Urinary Incontinence Sexual Dysfunction Device Pelvic floor exerciser,Devices
2,NCT00982293,The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes,Type 2 Diabetes,Device Resonator device Device Resonator device - sham,The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes Type 2 Diabetes Device Resonator device Device Resonator device  sham,Devices
2,NCT01775878,Diabetes Care Management Trial of Telemetric Monitoring,Diabetes,Device Telemonitoring Device,Diabetes Care Management Trial of Telemetric Monitoring Diabetes Device Telemonitoring Device,Devices
2,NCT03288792,A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts,Breast Cancer,Device RI8 device imaging,A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts Breast Cancer Device RI8 device imaging,Devices
2,NCT03277118,Quantifying Activity Using Wireless Wearable Technology,Activity Motor Sleep Delirium,Device Wireless Wearable Device,Quantifying Activity Using Wireless Wearable Technology Activity Motor Sleep Delirium Device Wireless Wearable Device,Devices
2,NCT04201639,Evaluating the Performance of Precision1 Daily Disposable Contact Lens in a Group of Heavy Digital Device Users,Myopia,Device Verofilcon A contact lenses,Evaluating the Performance of Precision1 Daily Disposable Contact Lens in a Group of Heavy Digital Device Users Myopia Device Verofilcon A contact lenses,Devices
2,NCT01770691,Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence,Stress Urinary Incontinence,Device TIPI vaginal pessary,Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence Stress Urinary Incontinence Device TIPI vaginal pessary,Devices
2,NCT02678715,Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy. Randomized Crossover Clinical Trial.,Temporomandibular Joint Dysfunction Syndrome Tooth Injuries Dental Occlusion Traumatic,Device Solubrux¶© Device Customized Appliance Device Somatics¶©,Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy. Randomized Crossover Clinical Trial. Temporomandibular Joint Dysfunction Syndrome Tooth Injuries Dental Occlusion Traumatic Device Solubrux¶© Device Customized Appliance Device Somatics¶©,Devices
2,NCT01637428,The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome,Post Thrombotic Syndrome,Device ActiveCare+S.F.T 3rd generation,The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome Post Thrombotic Syndrome Device ActiveCare+S.F.T 3rd generation,Devices
2,NCT01531504,New Use of the ViKY Device for Uterus Positioning,Surgical Procedure Unspecified,Device ViKY UP,New Use of the ViKY Device for Uterus Positioning Surgical Procedure Unspecified Device ViKY UP,Devices
2,NCT00811551,Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices,Heart Failure,Device CRT-D (Intra-thoracic Impedance Monitoring),Data Collection Study of Wedge Pressure Data in Patients With CRT D Devices Heart Failure Device CRT D (Intra thoracic Impedance Monitoring),Devices
2,NCT01592955,Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU),Glaucoma,Device EYEOP1,Glaucoma Treatment by Cyclo coagulation Using High Intensity Focused Ultrasound (HIFU) Glaucoma Device EYEOP1,Devices
2,NCT02255448,Evaluation of the esCCO Non-invasive Cardiac Output Measurement Device in Pregnancy,Pregnancy,Device Transthoracic echo and esCCO stroke volume,Evaluation of the esCCO Non invasive Cardiac Output Measurement Device in Pregnancy Pregnancy Device Transthoracic echo and esCCO stroke volume,Devices
2,NCT03252145,Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device,Lymphedema Secondary Lymphedema of Upper Limb,Device PhysioTouch Other Manual Lymph Drainage (MLD),Treatment of Breast Cancer related Lymphedema With a Negative Pressure Device Lymphedema Secondary Lymphedema of Upper Limb Device PhysioTouch Other Manual Lymph Drainage (MLD),Devices
2,NCT03807960,Information for Patient Controlled Analgesia Device,Postoperative Care Hysterectomy Health Communication,Other written form Other video Other routine care,Information for Patient Controlled Analgesia Device Postoperative Care Hysterectomy Health Communication Other written form Other video Other routine care,Devices
2,NCT01273961,Study of Radiofrequency Device for Use in Non-Invasive Cosmetic Procedures,Laxity of Skin,Device AuraLevÇ¸e treatment,Study of Radiofrequency Device for Use in Non Invasive Cosmetic Procedures Laxity of Skin Device AuraLevÇ¸e treatment,Devices
2,NCT01587287,A Comprehensive Assessment of Anterior Corneal Power by Different Devices,Myopia,Device Corneal power measurement,A Comprehensive Assessment of Anterior Corneal Power by Different Devices Myopia Device Corneal power measurement,Devices
2,NCT03035643,Device Ascyrus Medical Dissection Stent (AMDS),Aortic Dissection,Device Ascyrus Medical Dissection Stent placement,Device Ascyrus Medical Dissection Stent (AMDS) Aortic Dissection Device Ascyrus Medical Dissection Stent placement,Devices
2,NCT02032329,FastFES Gait Training for Stroke Patients Efficacy of Pre-Commercial Device,Stroke Gait,Device FastFES,FastFES Gait Training for Stroke Patients Efficacy of Pre Commercial Device Stroke Gait Device FastFES,Devices
2,NCT03507335,Atrial Fibrillation Detection 24 Hour Study,Arrhythmia Atrial Stroke,Device chest strap and PPG-device for monitoring the rhythm,Atrial Fibrillation Detection 24 Hour Study Arrhythmia Atrial Stroke Device chest strap and PPG device for monitoring the rhythm,Devices
2,NCT04048733,Timely Acquirement of 12-lead ECG Using Patchy-type Wireless Device Among Patient With Chest Pain,Chest Pain Electrocardiography,Device patchy-type wireless 12-lead ECG,Timely Acquirement of 12 lead ECG Using Patchy type Wireless Device Among Patient With Chest Pain Chest Pain Electrocardiography Device patchy type wireless 12 lead ECG,Devices
2,NCT00815776,Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial,Temporomandibular Disorders,Device Clayton Intra-aural Device (CID) Device Mouth Splint Other Exercise Group,Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra aural Device (CID) Clinical Trial Temporomandibular Disorders Device Clayton Intra aural Device (CID) Device Mouth Splint Other Exercise Group,Devices
2,NCT02944513,Efficacy of the Quell Wearable Device for Chronic Low Back Pain,Low Back Pain,Device Quell,Efficacy of the Quell Wearable Device for Chronic Low Back Pain Low Back Pain Device Quell,Devices
2,NCT01491373,Pilot Study of rhBMP-2/ACS/LT-CAGE¶© for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease,Degeneration of Lumbar Intervertebral Disc,Device rhBMP-2/ACS/LT-CAGE¶© Device Device Autograft/LT-CAGE¶© Device,Pilot Study of rhBMP 2 ACS LT CAGE¶© for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease Degeneration of Lumbar Intervertebral Disc Device rhBMP 2 ACS LT CAGE¶© Device Device Autograft LT CAGE¶© Device,Devices
2,NCT02597088,Development of Methods for Enhance Human Milk Presentation During Storage and Warming,Human Milk Breast Milk,Other Laboratory studies of the effect of human milk handling using a rage surface area bottle (study device),Development of Methods for Enhance Human Milk Presentation During Storage and Warming Human Milk Breast Milk Other Laboratory studies of the effect of human milk handling using a rage surface area bottle (study device),Devices
2,NCT03423784,Performance and Tolerability of a New Medical Device Gel a Randomized Open Label Parallel-group Multicentre Study,Tooth Disease,Device HA BPX V3.3 Other Dentinox-Gel N,Performance and Tolerability of a New Medical Device Gel a Randomized Open Label Parallel group Multicentre Study Tooth Disease Device HA BPX V3.3 Other Dentinox Gel N,Devices
2,NCT03465189,Validation of a Seizure Monitoring System,Epilepsy,Device Medtronic LINQ Device,Validation of a Seizure Monitoring System Epilepsy Device Medtronic LINQ Device,Devices
2,NCT01900288,Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research,Short Bowel Syndrome Malabsorption Malnutrition,Behavioral HPN Group Clinic Appointments using Mobile Devices (experimental) Behavioral Mobile Device Access (placebo),Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research Short Bowel Syndrome Malabsorption Malnutrition Behavioral HPN Group Clinic Appointments using Mobile Devices (experimental) Behavioral Mobile Device Access (placebo),Devices
2,NCT02512159,Skin Ulcers Treatment With an Handicraft Topical Device,Foot Ulcer Varicose Ulcer,Procedure drenovac handcrafted Procedure Healing,Skin Ulcers Treatment With an Handicraft Topical Device Foot Ulcer Varicose Ulcer Procedure drenovac handcrafted Procedure Healing,Devices
2,NCT00953290,Thigh Circumference Reduction Study,Reduction of Localized Excess Fat,Device Cutera Radio Frequency Device,Thigh Circumference Reduction Study Reduction of Localized Excess Fat Device Cutera Radio Frequency Device,Devices
2,NCT01653587,AngioSeal Versus Radial Approach in Acute Coronary Syndrome,Acute Coronary Syndrome,Device Percutaneous coronary intervention,AngioSeal Versus Radial Approach in Acute Coronary Syndrome Acute Coronary Syndrome Device Percutaneous coronary intervention,Devices
2,NCT03143556,Black Star - Magnetic Stent Removal in Transplant Patients,Kidney Failure Chronic End Stage Renal Failure With Renal Transplant,Device Magnetic stent,Black Star  Magnetic Stent Removal in Transplant Patients Kidney Failure Chronic End Stage Renal Failure With Renal Transplant Device Magnetic stent,Devices
2,NCT00189423,ResQ Trial Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest,Heart Arrest Death Sudden Cardiac Cardiopulmonary Resuscitation Cardiac Arrest,Device Use of an impedance threshold device (ITD) during the performance of active compression decompression CPR (ACD-CPR) Procedure Standard cardiopulmonary resuscitation (S-CPR),ResQ Trial Impact of an ITD and Active Compression Decompression CPR on Survival From Out of Hospital Cardiac Arrest Heart Arrest Death Sudden Cardiac Cardiopulmonary Resuscitation Cardiac Arrest Device Use of an impedance threshold device (ITD) during the performance of active compression decompression CPR (ACD CPR) Procedure Standard cardiopulmonary resuscitation (S CPR),Devices
2,NCT01558882,Impact of Essure Tubal Sterilization Devices on the Endometrium,Sterilization Tubal,Device Essure,Impact of Essure Tubal Sterilization Devices on the Endometrium Sterilization Tubal Device Essure,Devices
2,NCT03068598,Suicide Sleep Monitoring (Ssleem),Suicide Attempted,Device PulseOn watch/Suunto Spartan Ultra watch,Suicide Sleep Monitoring (Ssleem) Suicide Attempted Device PulseOn watch Suunto Spartan Ultra watch,Devices
2,NCT03736941,Impact of Venotrain UlcerteC Venous Compression Device in the Treatment of Venous Ulcers in Daily Practice,Venous Leg Ulcer,Other Patients with venous leg,Impact of Venotrain UlcerteC Venous Compression Device in the Treatment of Venous Ulcers in Daily Practice Venous Leg Ulcer Other Patients with venous leg,Devices
2,NCT02698605,Evaluation of the Arm Rehabilitation Device for Patients With Stroke,Stroke,Device Usability test study of the MirrorPath,Evaluation of the Arm Rehabilitation Device for Patients With Stroke Stroke Device Usability test study of the MirrorPath,Devices
2,NCT02400073,AutoSet for Her Quality of Life Clinical Trial,Obstructive Sleep Apnea,Device AutoSet for Her,AutoSet for Her Quality of Life Clinical Trial Obstructive Sleep Apnea Device AutoSet for Her,Devices
2,NCT02672007,Methods for the Measurement of Respiratory Rate,Respiratory Rate Measurement Methods.,Device SensiumVitals,Methods for the Measurement of Respiratory Rate Respiratory Rate Measurement Methods. Device SensiumVitals,Devices
2,NCT03588559,Clinical Trial of Blood Pressure Monitor in Conformance With the ANSI/AAMI ISO 81060-2 Standard,Blood Pressure,Diagnostic Test Blood Pressure Measurement,Clinical Trial of Blood Pressure Monitor in Conformance With the ANSI AAMI ISO 81060 2 Standard Blood Pressure Diagnostic Test Blood Pressure Measurement,Devices
2,NCT01745536,Closed Vitrification of Oocytes,Infertility,Procedure Oocytes are vitrified/stored using a closed device Procedure Oocytes are vitrified/stored using an open device,Closed Vitrification of Oocytes Infertility Procedure Oocytes are vitrified stored using a closed device Procedure Oocytes are vitrified stored using an open device,Devices
2,NCT02031627,Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device,Lower Extremity Lymphoedema Leg Lymphoedema,Device pneumatic compression - 1 hour per day Device pneumatic compression - 2 hours per day Device pneumatic compression - 4 hours per day,Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device Lower Extremity Lymphoedema Leg Lymphoedema Device pneumatic compression  1 hour per day Device pneumatic compression  2 hours per day Device pneumatic compression  4 hours per day,Devices
2,NCT01196897,Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE),Atrial Fibrillation,Device WATCHMAN LAA Closure Technology (Gen 4.0),Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non Valvular AF Patients (EVOLVE) Atrial Fibrillation Device WATCHMAN LAA Closure Technology (Gen 4.0),Devices
2,NCT00598819,A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers,Cerebral Ischemia,Device CDI 1000 COM,A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers Cerebral Ischemia Device CDI 1000 COM,Devices
2,NCT04155138,Recipients With Limited Bimodal Benefit HA or CROS,Cochlear Implant Hearing Disability Hearing Disorders and Deafness,Device Naida Hearing Aid Device Naida Contralateral Routing of Sound Device,Recipients With Limited Bimodal Benefit HA or CROS Cochlear Implant Hearing Disability Hearing Disorders and Deafness Device Naida Hearing Aid Device Naida Contralateral Routing of Sound Device,Devices
2,NCT02803879,Assessing the Capability of Cardiogoniometry (CGM) to Detect Changes in Cardiac Resynchronisation Therapy Device Settings,Heart Failure,Device Cardiogoniometry,Assessing the Capability of Cardiogoniometry (CGM) to Detect Changes in Cardiac Resynchronisation Therapy Device Settings Heart Failure Device Cardiogoniometry,Devices
2,NCT02784730,Iterative PICC Placement Versus Long Term Device,Breast Cancer,Procedure Iterative PICC placement Procedure Long term PAC placement,Iterative PICC Placement Versus Long Term Device Breast Cancer Procedure Iterative PICC placement Procedure Long term PAC placement,Devices
2,NCT04219566,Vestibular Nerve Stimulation to Improve Sleep,Insomnia Sleep Sleep Disorders Circadian Rhythm,Device VeNS Device Placebo device,Vestibular Nerve Stimulation to Improve Sleep Insomnia Sleep Sleep Disorders Circadian Rhythm Device VeNS Device Placebo device,Devices
2,NCT03086018,A Comparative Controlled Clinical Investigation and Quality Control of a New Hearing Aid,Hearing Loss,Device Successor hearing aid to Juna,A Comparative Controlled Clinical Investigation and Quality Control of a New Hearing Aid Hearing Loss Device Successor hearing aid to Juna,Devices
3,NCT03005106,StrataGraft¶© Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements,Trauma-related Wound|Burns|Skin Wound,Biological: StrataGraft Skin Tissue|Procedure: Autograft,StrataGraft¶© Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements Trauma-related Wound|Burns|Skin Wound Biological: StrataGraft Skin Tissue|Procedure: Autograft,Other
3,NCT03005054,StrataGraft¶© Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects,Trauma-related Wound|Burns|Skin Wound,Biological: StrataGraft Skin Tissue|Procedure: Autograft,StrataGraft¶© Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects Trauma-related Wound|Burns|Skin Wound Biological: StrataGraft Skin Tissue|Procedure: Autograft,Other
3,NCT02958345,Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavaxƒ?½,Herpes Zoster|Fibrosis,Biological: Zostavax|Other: Placebo,Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavaxƒ?½ Herpes Zoster|Fibrosis Biological: Zostavax|Other: Placebo,Other
3,NCT02922413,Panhematin for Prevention of Acute Attacks of Porphyria,Acute Intermittent Porphyria|Hereditary Coproporphyria|Variegate Porphyria,Biological: Hemin for injection|Other: Placebo,Panhematin for Prevention of Acute Attacks of Porphyria Acute Intermittent Porphyria|Hereditary Coproporphyria|Variegate Porphyria Biological: Hemin for injection|Other: Placebo,Other
3,NCT02868658,Asymptomatic Flu Project,Influenza,Biological: Blood sampling|Other: Nasal swab,Asymptomatic Flu Project Influenza Biological: Blood sampling|Other: Nasal swab,Other
3,NCT02860260,Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Patients With Ischemic Stroke,Ischemic Stroke,Biological: Blood samples|Other: Cerebral MRI,Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Patients With Ischemic Stroke Ischemic Stroke Biological: Blood samples|Other: Cerebral MRI,Other
3,NCT02857010,Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure,Acute on Chronic Hepatic Failure,Biological: Allogenic mesenchymal stem cells|Other: Placebo,Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure Acute on Chronic Hepatic Failure Biological: Allogenic mesenchymal stem cells|Other: Placebo,Other
3,NCT02856074,Functional Prognosis in Patients With Ischemic Stroke According to the Therapeutic Strategy Used,Ischemic Stroke,Biological: prise de sang|Other: quality of life questionnaire,Functional Prognosis in Patients With Ischemic Stroke According to the Therapeutic Strategy Used Ischemic Stroke Biological: prise de sang|Other: quality of life questionnaire,Other
3,NCT02844660,Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers,Diabetic Foot Ulcers,Biological: EpiCord|Other: Standard of Care,Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers Diabetic Foot Ulcers Biological: EpiCord|Other: Standard of Care,Other
3,NCT02828670,Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA),Autoimmune Hemolytic Anemia,Biological: blood sample|Procedure: spleen sample,Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA) Autoimmune Hemolytic Anemia Biological: blood sample|Procedure: spleen sample,Other
3,NCT02824107,Psychosocial Risk Factors in Stroke and Myocardial Infarction,Myocardial Infarction|Stroke,Biological: blood sample|Behavioral: questionnaires for psychosocial factors,Psychosocial Risk Factors in Stroke and Myocardial Infarction Myocardial Infarction|Stroke Biological: blood sample|Behavioral: questionnaires for psychosocial factors,Other
3,NCT02821572,Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP),Immune Thrombocytopenia,Biological: blood sample|Procedure: spleen sample,Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP) Immune Thrombocytopenia Biological: blood sample|Procedure: spleen sample,Other
3,NCT02779140,Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632,Botulism,Biological: NTM-1632|Other: Placebo,Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632 Botulism Biological: NTM-1632|Other: Placebo,Other
3,NCT02752594,Consumption of Probiotics on Salivary Bacteria Causing Dental Caries,Dental Caries,Biological: probiotic|Other: placebo,Consumption of Probiotics on Salivary Bacteria Causing Dental Caries Dental Caries Biological: probiotic|Other: placebo,Other
3,NCT02741518,Fecal Microbiota Transplantation for the Treatment of Obesity,Obesity,Biological: Fecal Microbiota Transplantation|Other: Placebo,Fecal Microbiota Transplantation for the Treatment of Obesity Obesity Biological: Fecal Microbiota Transplantation|Other: Placebo,Other
3,NCT02725996,By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy,Hepatocellular Carcinoma,Biological: NK cells|Other: Curative therapy,By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy Hepatocellular Carcinoma Biological: NK cells|Other: Curative therapy,Other
3,NCT02721264,Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.,Non Alcoholic Steatohepatitis,Biological: Fecal Microbiota Transplant|Other: Standard Medical Treatment,Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis. Non Alcoholic Steatohepatitis Biological: Fecal Microbiota Transplant|Other: Standard Medical Treatment,Other
3,NCT02718859,Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer,Pancreatic Cancer,Biological: NK cells|Procedure: irreversible electroporation (IRE ),Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer Pancreatic Cancer Biological: NK cells|Procedure: irreversible electroporation (IRE ),Other
3,NCT02716519,Use of Santyl Within an Accountable Care Organization,Pressure Ulcer|Foot Ulcer Diabetic,Biological: Santyl|Other: Standard Care,Use of Santyl Within an Accountable Care Organization Pressure Ulcer|Foot Ulcer Diabetic Biological: Santyl|Other: Standard Care,Other
3,NCT02704325,Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2,Duchenne Muscular Dystrophy,Biological: rAAVrh74.MCK.GALGT2|Other: PLACEBO (Saline),Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2 Duchenne Muscular Dystrophy Biological: rAAVrh74.MCK.GALGT2|Other: PLACEBO (Saline),Other
3,NCT02685722,UC-MSCs Gel Treatment Difficult Healing of Skin Ulcers,Difficult to Healing of Skin Ulcers,Biological: UC-MSCs Gel group|Other: Gel group,UC-MSCs Gel Treatment Difficult Healing of Skin Ulcers Difficult to Healing of Skin Ulcers Biological: UC-MSCs Gel group|Other: Gel group,Other
3,NCT02683629,Investigation of the Safety and Efficacy of NTCELL¶© [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease,Parkinson's Disease,Biological: NTCELL Implantation|Other: Sham Surgery,Investigation of the Safety and Efficacy of NTCELL¶© [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease Parkinson's Disease Biological: NTCELL Implantation|Other: Sham Surgery,Other
3,NCT02679807,Effect of Probiotic on Rhinovirus Induced Colds,Common Cold,Biological: Bifidobacterium animalis subsp. lactis Bl-04|Other: sucrose,Effect of Probiotic on Rhinovirus Induced Colds Common Cold Biological: Bifidobacterium animalis subsp. lactis Bl-04|Other: sucrose,Other
3,NCT02619877,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers,Diabetic Foot Ulcer,Biological: ALLO-ASC-DFU|Other: Standard therapy,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers Diabetic Foot Ulcer Biological: ALLO-ASC-DFU|Other: Standard therapy,Other
3,NCT02612428,Randomized Open-Label Multicenter Controlled Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD,Acute Alcoholic Hepatitis,Biological: ELAD System|Other: Standard of Care (Control),Randomized Open-Label Multicenter Controlled Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD Acute Alcoholic Hepatitis Biological: ELAD System|Other: Standard of Care (Control),Other
3,NCT02607462,PRP Therapy to m. Gluteus Medius During THA,Hip Osteoarthritis,Biological: PRP|Other: Placebo,PRP Therapy to m. Gluteus Medius During THA Hip Osteoarthritis Biological: PRP|Other: Placebo,Other
3,NCT02605525,Efficacy and Safety of SM101 in the Treatment of IgA Nephropathy,Immunoglobulin A Nephropathy,Biological: SM101|Other: Placebo,Efficacy and Safety of SM101 in the Treatment of IgA Nephropathy Immunoglobulin A Nephropathy Biological: SM101|Other: Placebo,Other
3,NCT02597647,Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection,Influenza,Biological: LAIV|Other: Saline,Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection Influenza Biological: LAIV|Other: Saline,Other
3,NCT02582489,Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy,Osteoarthritis Post-meniscectomy,Biological: Bone Marrow Aspirate Concentrate|Procedure: Standard Meniscectomy,Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy Osteoarthritis Post-meniscectomy Biological: Bone Marrow Aspirate Concentrate|Procedure: Standard Meniscectomy,Other
3,NCT02555085,Single Ascending Doses of BIIB063 in Healthy Volunteers,Healthy,Biological: BIIB063|Other: Placebo,Single Ascending Doses of BIIB063 in Healthy Volunteers Healthy Biological: BIIB063|Other: Placebo,Other
3,NCT02540655,Efficacy and Safety Study of Stemchymal¶© in Polyglutamine Spinocerebellar Ataxia,Cerebellar Ataxia,Biological: Stemchymal¶©|Procedure: Excipients,Efficacy and Safety Study of Stemchymal¶© in Polyglutamine Spinocerebellar Ataxia Cerebellar Ataxia Biological: Stemchymal¶©|Procedure: Excipients,Other
3,NCT02533895,Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood,Childhood Solid Tumor,Biological: AV0113 DC-CIT|Other: Data evaluation,Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood Childhood Solid Tumor Biological: AV0113 DC-CIT|Other: Data evaluation,Other
3,NCT02533830,Gum Chewing And Bowel Motility in Patients Undergoing Cesarean Section. Kasr el Ainy Experience,Gum Chewing|Bowel Function,Biological: sugarless gum|Other: traditional management,Gum Chewing And Bowel Motility in Patients Undergoing Cesarean Section. Kasr el Ainy Experience Gum Chewing|Bowel Function Biological: sugarless gum|Other: traditional management,Other
3,NCT02526576,Adipose Derived Stem Cells in Facial Fat Grafting,Facial Atrophy,Biological: Stromal Vasular Fraction|Procedure: Biopsy,Adipose Derived Stem Cells in Facial Fat Grafting Facial Atrophy Biological: Stromal Vasular Fraction|Procedure: Biopsy,Other
3,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma,Adult Brain Glioblastoma|Adult Gliosarcoma|Recurrent Brain Neoplasm,Biological: EGFRBi-Armed Autologous T Cells|Other: Laboratory Biomarker Analysis,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma Adult Brain Glioblastoma|Adult Gliosarcoma|Recurrent Brain Neoplasm Biological: EGFRBi-Armed Autologous T Cells|Other: Laboratory Biomarker Analysis,Other
3,NCT03796611,Phenotypic and Functional Study of 4BL B Cells in Multiple Sclerosis (MS),Multiple Sclerosis,,Phenotypic and Functional Study of 4BL B Cells in Multiple Sclerosis (MS) Multiple Sclerosis ,Other
3,NCT02500550,Safety and Efficacy of Two Doses of ATIR101 a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome,Biological: ATIR101|Procedure: Haploidentical hematopoietic stem cell transplantation (HSCT),Safety and Efficacy of Two Doses of ATIR101 a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome Biological: ATIR101|Procedure: Haploidentical hematopoietic stem cell transplantation (HSCT),Other
3,NCT02480699,Intra Individual Evaluation of Uremic Toxin Levels in Hemodialysed Patients,Chronic Kidney Disease,Biological: Recurring blood sample|Other: dietary survey,Intra Individual Evaluation of Uremic Toxin Levels in Hemodialysed Patients Chronic Kidney Disease Biological: Recurring blood sample|Other: dietary survey,Other
3,NCT02479698,Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus,Acquired Immunodeficiency Syndrome|BK Virus Infection|Human Immunodeficiency Virus|JC Virus Infection|Malignant Neoplasm|Merkel Cell Carcinoma|Merkel Cell Polyomavirus Infection|Viral Encephalitis,Biological: Allogeneic BK-specific Cytotoxic T-lymphocytes|Other: Laboratory Biomarker Analysis,Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus Acquired Immunodeficiency Syndrome|BK Virus Infection|Human Immunodeficiency Virus|JC Virus Infection|Malignant Neoplasm|Merkel Cell Carcinoma|Merkel Cell Polyomavirus Infection|Viral Encephalitis Biological: Allogeneic BK-specific Cytotoxic T-lymphocytes|Other: Laboratory Biomarker Analysis,Other
3,NCT02476734,FDG-PET/CT Imaging as Early Predictor of DP,Lymphoma,Biological: CART-19 autologous T-cells|Radiation: FDG-PET/CT,FDG-PET/CT Imaging as Early Predictor of DP Lymphoma Biological: CART-19 autologous T-cells|Radiation: FDG-PET/CT,Other
3,NCT02473224,Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies,Gastroenteritis Norovirus,Biological: Norovirus GII.2 Challenge|Other: Placebo,Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies Gastroenteritis Norovirus Biological: Norovirus GII.2 Challenge|Other: Placebo,Other
3,NCT02448173,A Multicenter Study of Active Specific Immunotherapy With OncoVax¶© in Patients With Stage II Colon Cancer,Stage II Colon Cancer,Biological: OncoVAX and Surgery|Procedure: Surgery,A Multicenter Study of Active Specific Immunotherapy With OncoVax¶© in Patients With Stage II Colon Cancer Stage II Colon Cancer Biological: OncoVAX and Surgery|Procedure: Surgery,Other
3,NCT02442570,A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis,Multiple Sclerosis,Biological: recombinant human alpha B-crystallin|Other: Placebo comparator,A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis Multiple Sclerosis Biological: recombinant human alpha B-crystallin|Other: Placebo comparator,Other
3,NCT02442557,Safety and Dose-finding Study of DC-TAB in Healthy Subjects,Multiple Sclerosis,Biological: recombinant human alpha B-crystallin|Other: placebo comparator,Safety and Dose-finding Study of DC-TAB in Healthy Subjects Multiple Sclerosis Biological: recombinant human alpha B-crystallin|Other: placebo comparator,Other
3,NCT04252534,Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma,Retinitis Pigmentosa,Combination Product: PRP combined Magnovision|Biological: PRP,Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma Retinitis Pigmentosa Combination Product: PRP combined Magnovision|Biological: PRP,Other
3,NCT04007575,Study of New Imaging Criteria for the Diagnosis of Caroli's Disease,Caroli Disease|Magnetic Resonance Imaging|Cholangiopancreatography,Diagnostic Test: Magnetic Resonance CholangioPancreatography,Study of New Imaging Criteria for the Diagnosis of Caroli's Disease Caroli Disease|Magnetic Resonance Imaging|Cholangiopancreatography Diagnostic Test: Magnetic Resonance CholangioPancreatography,Other
3,NCT02370420,Intra-Articular Injections of Platelet-Rich Plasma in Knee Osteoarthritis: Unique Application Versus Triple Application,Osteoarthritis,Biological: Platelet-Rich Plasma|Behavioral: rehabilitation exercises,Intra-Articular Injections of Platelet-Rich Plasma in Knee Osteoarthritis: Unique Application Versus Triple Application Osteoarthritis Biological: Platelet-Rich Plasma|Behavioral: rehabilitation exercises,Other
3,NCT04187222,Effect of Probiotic Use Bifidobacterium Animalis Subsp. Lactis in Peri-implant Mucositis,Mucositis Oral,Other: Mechanical debridements|Biological: Bifidobacterium animalis subsp. lactis,Effect of Probiotic Use Bifidobacterium Animalis Subsp. Lactis in Peri-implant Mucositis Mucositis Oral Other: Mechanical debridements|Biological: Bifidobacterium animalis subsp. lactis,Other
3,NCT02350205,SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma,Burns,Biological: Self assembled skin substitute (SASS)|Procedure: Split-thickness autograft,SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma Burns Biological: Self assembled skin substitute (SASS)|Procedure: Split-thickness autograft,Other
3,NCT02337842,Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1),Gastroenteritis Norovirus,Biological: Norovirus GII.4 Challenge Pool CIN-1|Other: Placebo,Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1) Gastroenteritis Norovirus Biological: Norovirus GII.4 Challenge Pool CIN-1|Other: Placebo,Other
3,NCT02334878,Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence,Urinary Incontinence Stress,Biological: Stem CellsMesenchymal|Procedure: surgery (TVT),Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence Urinary Incontinence Stress Biological: Stem CellsMesenchymal|Procedure: surgery (TVT),Other
3,NCT02316717,A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis,Non-alcoholic Steatohepatitis (NASH),Biological: IMM-124E|Other: Placebo,A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis (NASH) Biological: IMM-124E|Other: Placebo,Other
3,NCT04095715,Anomalies of Dense Platelet Granules,Spontaneous Induced Unexplained Haemorrhagic,Other: Haemostasis consultation|Biological: Standard management of patients suspected of thrombopathy,Anomalies of Dense Platelet Granules Spontaneous Induced Unexplained Haemorrhagic Other: Haemostasis consultation|Biological: Standard management of patients suspected of thrombopathy,Other
3,NCT02280135,Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa,Retinitis Pigmentosa,Biological: Intravitreal injection of Autologous bone marrow Stem Cell|Other: Subconjunctival injection of saline,Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa Retinitis Pigmentosa Biological: Intravitreal injection of Autologous bone marrow Stem Cell|Other: Subconjunctival injection of saline,Other
3,NCT02277574,Assess Safety Tolerability Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis,Rheumatoid Arthritis,Biological: AMP-110|Other: Placebo,Assess Safety Tolerability Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis Biological: AMP-110|Other: Placebo,Other
3,NCT02269150,Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation,Allogeneic Hematopoietic Stem Cell,Biological: fecal microbiota transplantation (FMT)|Other: No fecal microbiota transplantation (FMT) routine management,Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Allogeneic Hematopoietic Stem Cell Biological: fecal microbiota transplantation (FMT)|Other: No fecal microbiota transplantation (FMT) routine management,Other
3,NCT02250248,AttraX¶© Putty vs. Autograft in XLIF¶©,Degenerative Conditions of the Lumbar Spine,Biological: AttraX Putty|Other: Iliac Crest Bone Graft (ICBG),AttraX¶© Putty vs. Autograft in XLIF¶© Degenerative Conditions of the Lumbar Spine Biological: AttraX Putty|Other: Iliac Crest Bone Graft (ICBG),Other
3,NCT04030676,QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis,Cytomegalovirus Infections,Procedure: Biopsies|Biological: Blood samples,QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis Cytomegalovirus Infections Procedure: Biopsies|Biological: Blood samples,Other
3,NCT03984669,(13)-BÇ¸ta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity's Disease : a Cohort Sudy,Juvenile Idiopathic Arthritis,Diagnostic Test: The Juvenile Disease Activity Score (JADAS)|Biological: (1-3)-Ç?-D-Glucan (BDG) assay (Fungitell),(13)-BÇ¸ta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity's Disease : a Cohort Sudy Juvenile Idiopathic Arthritis Diagnostic Test: The Juvenile Disease Activity Score (JADAS)|Biological: (1-3)-Ç?-D-Glucan (BDG) assay (Fungitell),Other
3,NCT03783390,Brain Appetite Teens and Exercise,Energy Balance|Appetitive Behavior|Obesity,Behavioral: Exercise Intervention|Behavioral: Newsletter,Brain Appetite Teens and Exercise Energy Balance|Appetitive Behavior|Obesity Behavioral: Exercise Intervention|Behavioral: Newsletter,Other
3,NCT02196467,Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients,Duchenne Muscular Dystrophy,Biological: Myoblast transplantation|Procedure: Saline injection,Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients Duchenne Muscular Dystrophy Biological: Myoblast transplantation|Procedure: Saline injection,Other
3,NCT02184676,T1D Risk Assessment in Kids With Relatives,Type 1 Diabetes,Biological: Analysis of early immune modifications|Other: Collection of clinical and socio-demographic data,T1D Risk Assessment in Kids With Relatives Type 1 Diabetes Biological: Analysis of early immune modifications|Other: Collection of clinical and socio-demographic data,Other
3,NCT02180412,Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria,Acute Porphyrias,Biological: Panhematin|Other: Glucose,Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria Acute Porphyrias Biological: Panhematin|Other: Glucose,Other
3,NCT03920800,Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions,High-Grade Squamous Intraepithelial Lesions,Other: Data extraction from medical files|Biological: Immunohistochemistry,Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions High-Grade Squamous Intraepithelial Lesions Other: Data extraction from medical files|Biological: Immunohistochemistry,Other
3,NCT02166255,APN401 in Treating Patients With Melanoma Kidney Cancer Pancreatic Cancer or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery,Recurrent Melanoma|Recurrent Pancreatic Cancer|Recurrent Renal Cell Cancer|Stage III Pancreatic Cancer|Stage III Renal Cell Cancer|Stage IIIA Melanoma|Stage IIIB Melanoma|Stage IIIC Melanoma|Stage IV Melanoma|Stage IV Pancreatic Cancer|Stage IV Renal Cell Cancer|Unspecified Adult Solid Tumor Protocol Specific,Biological: siRNA-transfected peripheral blood mononuclear cells APN401|Other: laboratory biomarker analysis,APN401 in Treating Patients With Melanoma Kidney Cancer Pancreatic Cancer or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery Recurrent Melanoma|Recurrent Pancreatic Cancer|Recurrent Renal Cell Cancer|Stage III Pancreatic Cancer|Stage III Renal Cell Cancer|Stage IIIA Melanoma|Stage IIIB Melanoma|Stage IIIC Melanoma|Stage IV Melanoma|Stage IV Pancreatic Cancer|Stage IV Renal Cell Cancer|Unspecified Adult Solid Tumor Protocol Specific Biological: siRNA-transfected peripheral blood mononuclear cells APN401|Other: laboratory biomarker analysis,Other
3,NCT02154867,Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial.,Irritable Bowel Syndrome,Biological: Fecal transplantation|Other: Placebo fecal transplant,Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial. Irritable Bowel Syndrome Biological: Fecal transplantation|Other: Placebo fecal transplant,Other
3,NCT02140112,Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder,Autism,Biological: Trichuris suis ova|Other: Placebo,Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder Autism Biological: Trichuris suis ova|Other: Placebo,Other
3,NCT02130310,Evaluation of CureXcell¶© in Treating Chronic Venous Leg Ulcers,Chronic Venous Leg Ulcers,Biological: CureXcell¶©|Other: Placebo injection,Evaluation of CureXcell¶© in Treating Chronic Venous Leg Ulcers Chronic Venous Leg Ulcers Biological: CureXcell¶©|Other: Placebo injection,Other
3,NCT02094885,The Bioseal Vascular Study,Cardiovascular Bleeding|Vascular Bleeding|Hemorrhage,Biological: Bioseal Fibrin Sealant|Other: Manual Compression,The Bioseal Vascular Study Cardiovascular Bleeding|Vascular Bleeding|Hemorrhage Biological: Bioseal Fibrin Sealant|Other: Manual Compression,Other
3,NCT03804112,TransIent Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: Clinical and Radiological Follow-up,Cervical Pain|Vasculitis,Diagnostic Test: Ultrasound exam with Doppler|Biological: Blood samples,TransIent Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: Clinical and Radiological Follow-up Cervical Pain|Vasculitis Diagnostic Test: Ultrasound exam with Doppler|Biological: Blood samples,Other
3,NCT02087904,A Study Evaluating the Safety Efficacy and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis,Knee Osteoarthritis|Medial Compartment Knee Osteoarthritis,Biological: ABT-981|Other: Placebo,A Study Evaluating the Safety Efficacy and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis Knee Osteoarthritis|Medial Compartment Knee Osteoarthritis Biological: ABT-981|Other: Placebo,Other
3,NCT02057211,Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study,Type 1 Diabetes Mellitus,Biological: autologous mesenchymal stem cell transplantation|Procedure: sham transplantation of mesenchymal stem cells,Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study Type 1 Diabetes Mellitus Biological: autologous mesenchymal stem cell transplantation|Procedure: sham transplantation of mesenchymal stem cells,Other
3,NCT02054208,Safety and Exploratory Efficacy Study of NEUROSTEM¶© Versus Placebo in Patients With Alzheimer's Disease,Alzheimer's Disease,Biological: human umbilical cord blood derived mesenchymal stem cells|Other: Normal saline 2mL,Safety and Exploratory Efficacy Study of NEUROSTEM¶© Versus Placebo in Patients With Alzheimer's Disease Alzheimer's Disease Biological: human umbilical cord blood derived mesenchymal stem cells|Other: Normal saline 2mL,Other
3,NCT02034799,Phase IV Bioseal Study in Brain Tumor Surgery,Hemostasis|Meningioma Surgery,Biological: Bioseal Fibrin Sealant|Other: Standard of Care (SoC),Phase IV Bioseal Study in Brain Tumor Surgery Hemostasis|Meningioma Surgery Biological: Bioseal Fibrin Sealant|Other: Standard of Care (SoC),Other
3,NCT02005848,Phase II Study to Evaluate the Efficacy and Safety of Glassia¶© in Type-1 Diabetes,New Onset Type-1 Diabetes,Biological: Alpha-1 Antitrypsin|Other: Placebo,Phase II Study to Evaluate the Efficacy and Safety of Glassia¶© in Type-1 Diabetes New Onset Type-1 Diabetes Biological: Alpha-1 Antitrypsin|Other: Placebo,Other
3,NCT01982474,Safety of Lymph Node Injection for Allergen Immunotherapy,Allergic Rhinitis,Biological: Grass pollen extract|Other: Placebo injection,Safety of Lymph Node Injection for Allergen Immunotherapy Allergic Rhinitis Biological: Grass pollen extract|Other: Placebo injection,Other
3,NCT01978561,Follow-Up Of Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up),Repeated IVF Failure,Biological: Post dosing with NT100|Other: Post dosing with Placebo,Follow-Up Of Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up) Repeated IVF Failure Biological: Post dosing with NT100|Other: Post dosing with Placebo,Other
3,NCT03633500,Effectiveness of Oral Immunotherapy Among Preterm Babies,Feeding Behavior|Late-Onset Neonatal Sepsis,Other: Sterile water|Biological: Breastmilk,Effectiveness of Oral Immunotherapy Among Preterm Babies Feeding Behavior|Late-Onset Neonatal Sepsis Other: Sterile water|Biological: Breastmilk,Other
3,NCT01950975,Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism.,Malformations With Skin Manifestations Suggesting Mosaicism,Biological: Peripheral blood samples in EDTA tubes|Procedure: Skin biopsies,Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism. Malformations With Skin Manifestations Suggesting Mosaicism Biological: Peripheral blood samples in EDTA tubes|Procedure: Skin biopsies,Other
3,NCT03550833,Impact of Life Events and Psychological Stress in Rheumatoid Arthritis Set-up : Case-control Study Within a Multifactorial and Integrative Psychological Model,Arthritis Rheumatoid|Stress Disorder,Behavioral: Questionnaire|Biological: blood sample,Impact of Life Events and Psychological Stress in Rheumatoid Arthritis Set-up : Case-control Study Within a Multifactorial and Integrative Psychological Model Arthritis Rheumatoid|Stress Disorder Behavioral: Questionnaire|Biological: blood sample,Other
3,NCT01896635,Faecal Microbiota Transplantation in Ulcerative Colitis,Ulcerative Colitis|Inflammatory Bowel Disease,Biological: FMT infusions|Other: Placebo infusion,Faecal Microbiota Transplantation in Ulcerative Colitis Ulcerative Colitis|Inflammatory Bowel Disease Biological: FMT infusions|Other: Placebo infusion,Other
3,NCT01873547,Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China,Spinal Cord Injury,Biological: cell therapy|Other: rehabilitation,Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China Spinal Cord Injury Biological: cell therapy|Other: rehabilitation,Other
